Capsid Assembly Modulators as Antiviral Agents against HBV: Molecular Mechanisms and Clinical Perspectives

Despite a preventive vaccine being available, more than 250 million people suffer from chronic hepatitis B virus (HBV) infection, a major cause of liver disease and HCC. HBV infects human hepatocytes where it establishes its genome, the cccDNA with chromosomal features. Therapies controlling HBV rep...

Descripción completa

Detalles Bibliográficos
Autores principales: Taverniti, Valerio, Ligat, Gaëtan, Debing, Yannick, Kum, Dieudonne Buh, Baumert, Thomas F., Verrier, Eloi R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911156/
https://www.ncbi.nlm.nih.gov/pubmed/35268440
http://dx.doi.org/10.3390/jcm11051349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8911156/
https://www.ncbi.nlm.nih.gov/pubmed/35268440
http://dx.doi.org/10.3390/jcm11051349

Ejemplares similares